Research programme: CR1 - Nuada
Alternative Names: CR1 research programme - Nuada; Research programme: TNFalpha production inhibitors - Nuada; TNFalpha production inhibitors research programme - NuadaLatest Information Update: 08 Feb 2008
At a glance
- Originator Nuada Pharmaceuticals
- Class Small molecules
- Mechanism of Action Tumour necrosis factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammatory bowel diseases; Psoriasis; Rheumatoid arthritis
Most Recent Events
- 09 Jun 2004 Preclinical trials in Inflammatory bowel disease in USA (PO)
- 23 Mar 2004 Nuada's CR1 programme is available for partnering (http://www.nuadapharma.com)
- 23 Mar 2004 Preclinical trials in Psoriasis in USA (PO)